Viveve Geneveve Treatment of the Vaginal Introitus to Evaluate Safety and Efficacy
Public ClinicalTrials.gov record NCT03479229. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is evaluating the safety and efficacy of the Geneveve Treatment for women experiencing diminished sexual function following vaginal childbirth. Participants will be randomized to either active or sham treatment and followed for 12 months.
Study identification
- NCT ID
- NCT03479229
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 250 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 20, 2018 (Actual)
- Primary completion
- Mar 15, 2020 (Actual)
- Completion
- Mar 15, 2020 (Actual)
- Last update posted
- May 19, 2020
2018 – 2020
United States locations
- U.S. sites
- 19
- U.S. states
- 16
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| VIVEVE II Study Site | La Mesa | California | 91942 | — |
| VIVEVE II Study Site | Orange | California | 92868 | — |
| VIVEVE II Study Site | Denver | Colorado | 80209 | — |
| VIVEVE II Study Site | Washington D.C. | District of Columbia | 20036 | — |
| VIVEVE II Study Site | Lake Worth | Florida | 33461 | — |
| VIVEVE II Study Site | Plantation | Florida | 33324 | — |
| VIVEVE II Study Site | West Palm Beach | Florida | 33409 | — |
| VIVEVE II Study Site | Atlanta | Georgia | 30342 | — |
| VIVEVE II Study Site | Idaho Falls | Idaho | 83404 | — |
| VIVEVE II Study Site | Kalamazoo | Michigan | 49009 | — |
| VIVEVE II Study Site | St Louis | Missouri | 63117 | — |
| VIVEVE II Study Site | Omaha | Nebraska | 68114 | — |
| VIVEVE II Study Site | New Brunswick | New Jersey | 08901 | — |
| VIVEVE II Study Site | Albuquerque | New Mexico | 87131 | — |
| VIVEVE II Study Site | New York | New York | 10038 | — |
| VIVEVE II Study Site | Raleigh | North Carolina | 27612 | — |
| VIVEVE II Study Site | Columbus | Ohio | 43221 | — |
| VIVEVE II Study Site | Jackson | Tennessee | 38305 | — |
| VIVEVE II Study Site | Tacoma | Washington | 98042 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03479229, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 19, 2020 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03479229 live on ClinicalTrials.gov.